| 摘要 |
<p>The invention relates to means for the prognosis and/or diagnosis of antiphospholipid syndrome (APS). In particular, the invention enables differentiation between subjects suffering and/or at risk of suffering from APS and subjects that exhibit elevated levels of antiphospholipid antibodies (aPL) without clinical manifestations or with reduced risk of exhibiting clinical manifestations or a clinical phenotype of APS.</p> |
